Delivery Order SPE2DE24D0013-SPE2D625F3KDF
- Not listed
- The U.S. Defense Department's Medical Supply Chain agency awarded a $13,600 firm fixed-price delivery order to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions. Issued on August 14, 2025, with an ultimate completion date of August 21, 2025, this delivery order (XPRS4PLEX-10) carries no set-aside designation and represents a short-term procurement under one of Cepheid's existing indefinite delivery vehicle contracts. The place of performance is Sunnyvale,...
- The U.S. Defense Department's Medical Supply Chain agency awarded a $1,800 firm fixed-price delivery order to Cepheid Inc., a leading molecular diagnostics manufacturer headquartered in Sunnyvale, California. This delivery order, issued on August 25, 2025, with an ultimate completion date of September 2, 2025, carries no set-aside designation and represents a continuation of the agency's procurement of advanced diagnostic solutions. The work will be performed at Cepheid's Sunnyvale facility....
- The Defense Logistics Agency has awarded a $13.6K delivery order (XPRS4PLEX-10) to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions. This firm fixed-price delivery order, awarded on September 11, 2025, with an ultimate completion date of September 18, 2025, represents a continuation of the federal government's procurement of Cepheid's diagnostic testing capabilities. The award carries no set-aside designation and will be performed at Cepheid's...
- The U.S. Defense Department's Medical Supply Chain agency awarded a delivery order valued at $1,361.79 to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions. This firm fixed-price delivery order, issued on August 20, 2025, with an ultimate completion date of August 27, 2025, represents work to be performed at Cepheid's Sunnyvale facility. The contract carries no set-aside designation and is identified as delivery order XPRSMVP-10 under contract number...
- The Defense Department's Medical Supply Chain awarded a $16.2K delivery order to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, on August 27, 2025, with an ultimate completion date of September 4, 2025. This firm fixed-price delivery order carries no set-aside designation and represents a continuation of the Department's procurement of diagnostic testing capabilities through Cepheid's established federal contracting vehicles. Cepheid specializes in...
- The U.S. Defense Logistics Agency (under the Medical Supply Chain division) awarded a firm fixed-price delivery order valued at $8,820.00 to Cepheid Inc., a leading manufacturer of molecular diagnostic solutions headquartered in Sunnyvale, California. The delivery order, issued on August 21, 2025, with an ultimate completion date of August 28, 2025, carries no set-aside designation and will be performed at Cepheid's Sunnyvale facility. This award represents a continuation of Cepheid's ongoing...
- The U.S. Defense Logistics Agency, operating under the Medical Supply Chain division, awarded a $5,520 firm fixed-price delivery order to Cepheid Inc. on August 20, 2025, with an ultimate completion date of August 27, 2025. This delivery order, designated XPRSTREPA-10, carries no set-aside designation and will be performed at Cepheid's facility in Sunnyvale, California. The contract represents a procurement of molecular diagnostic solutions from Cepheid, a specialized manufacturer of advanced...
- The U.S. Defense Department's Medical Supply Chain division awarded a $19,375 firm fixed-price delivery order to Cepheid Inc. on September 8, 2025, with an ultimate completion date of September 15, 2025. This delivery order (XPRS4PLEX-10) represents a continuation of the federal government's ongoing procurement of molecular diagnostic solutions from the Sunnyvale, California-based manufacturer. The award carries no set-aside designation and is likely issued under one of Cepheid's existing...
- The U.S. Defense Department's Medical Supply Chain organization awarded a delivery order valued at $1,190.28 to Cepheid Inc. on August 14, 2025, with an ultimate completion date of August 28, 2025. This firm fixed-price delivery order does not utilize any set-aside designation and represents a discrete procurement under a broader federal vehicle. Cepheid, a molecular diagnostics manufacturer based in Sunnyvale, California, specializes in providing advanced diagnostic systems and test kits for...
- The U.S. Defense Logistics Agency, operating under the Medical Supply Chain division, awarded a $47,924 firm fixed-price delivery order to Cepheid Inc., a leading manufacturer of molecular diagnostic solutions based in Sunnyvale, California. This delivery order, designated XPRSTREPA-10, carries an ultimate completion date of September 9, 2025, and represents work to be performed at Cepheid's Sunnyvale facility. The contract was awarded without set-aside designation on September 2, 2025,...
- SPE2DE24D0013Indefinite Delivery Contract
- SPE2DE24D0013-SPE2D625F3KDFDelivery Order
The U.S. Defense Logistics Agency's Medical Supply Chain division awarded a $26,627.40 delivery order (XPRSMVP-10) to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, with a completion date of September 26, 2025. This firm fixed-price delivery order carries no set-aside designation and represents a continuation of the agency's procurement of diagnostic testing solutions from Cepheid, a company specializing in advanced molecular diagnostic systems and reagents for infectious disease detection and clinical testing. Cepheid maintains significant federal presence through multiple indefinite delivery contracts with the Department of Veterans Affairs, including a $32.8 million single-award IDV with VA's Veterans Integrated Service Network 6 focused on molecular diagnostic testing system reagents and assays through 2030. The current delivery order aligns with the company's core federal business of providing GeneXpert diagnostic systems, test kits, and maintenance services for detecting conditions including COVID-19, influenza, respiratory syncytial virus, and other infectious diseases across federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $26.6k | 9/12/25 |